SEC registrant · CIK 0001479681

Nutex Health Inc. (NUTX)

Nutex Health Inc. (CIK 0001479681, ticker NUTX, EIN 11-3363609) reported revenue of $875.26 million ($875,257,000) for FY2025 (2025-01-01 to 2025-12-31) and net income of $70.79 million ($70,789,000) for FY2025 (2025-01-01 to 2025-12-31), as filed in its 10-K filed 2026-03-05 (accession 0001628280-26-015168).

Figures are as filed with the SEC in XBRL, in whole US dollars unless stated, for the company's own fiscal years (fiscal year ends December 31).

Data as of Oct 21, 2026 (Olympus publication) · Markdown version

  • Values are as filed by the company in its 10-K and 10-Q XBRL data. When a later filing restates a value, the latest filed value is shown and the first reported value is noted.

Identifiers

As published in the company's EDGAR submissions record.

IdentifierValue
CIK0001479681
TickersNUTX (Nasdaq)
EIN11-3363609
SIC industry code7389 Services-Business Services, NEC
State or country of incorporationDE
Fiscal year endDecember 31
Filer categoryAccelerated filer
Entity typeoperating
Olympus entity IDorg_68kh9v2yqngfce8tsaj0eds6n1
  • The EIN is the one the filer gave to EDGAR. The SEC does not verify it; Olympus checks only that it has nine digits and a prefix the IRS assigns.

Latest annual financial metrics

The latest annual value of each standardised metric, with the filing it was taken from.

MetricValueFiscal periodPeriodFormFiledAccession numberXBRL concept
Revenue$875,257,000FY20252025-01-01 to 2025-12-3110-K2026-03-050001628280-26-015168Revenues
Net income$70,789,000FY20252025-01-01 to 2025-12-3110-K2026-03-050001628280-26-015168NetIncomeLoss
Total assets$918,525,000FY2025as of 2025-12-3110-K2026-03-050001628280-26-015168Assets
Total liabilities$495,088,000FY2025as of 2025-12-3110-K2026-03-050001628280-26-015168Liabilities
Stockholders' equity$329,447,000FY2025as of 2025-12-3110-K2026-03-050001628280-26-015168StockholdersEquity
Operating cash flow$248,125,000FY20252025-01-01 to 2025-12-3110-K2026-03-050001628280-26-015168NetCashProvidedByUsedInOperatingActivities
Diluted earnings per share$10.48 per shareFY20252025-01-01 to 2025-12-3110-K2026-03-050001628280-26-015168EarningsPerShareDiluted
Shares outstanding6,968,350 sharesFY2025as of 2026-03-0210-K2026-03-050001628280-26-015168EntityCommonStockSharesOutstanding
  • Accession numbers link to the filing's index on SEC EDGAR.

Revenue and net income history

Every annual revenue and net income value served for fiscal years 2016-2025, newest first, each with its filing.

MetricFiscal periodPeriodValueFormFiledAccession number
RevenueFY20252025-01-01 to 2025-12-31$875,257,00010-K2026-03-050001628280-26-015168
RevenueFY20242024-01-01 to 2024-12-31$479,949,00010-K2026-03-050001628280-26-015168
RevenueFY20232023-01-01 to 2023-12-31$247,646,00010-K2026-03-050001628280-26-015168
RevenueFY20222022-01-01 to 2022-12-31$219,294,30610-K/A2025-11-180001628280-25-052895
RevenueFY20212021-01-01 to 2021-12-31$331,531,31110-K2024-03-290001558370-24-004287
RevenueFY20202020-01-01 to 2020-12-31$274,029,06110-K2023-03-030001558370-23-002713
RevenueFY20192019-01-01 to 2019-12-31$1,366,41910-K2021-04-050001607062-21-000074
RevenueFY20182018-01-01 to 2018-12-31$1,366,99610-K2020-05-140001607062-20-000125
RevenueFY20172017-01-01 to 2017-12-31$23,16610-K/A2019-04-170001607062-19-000163
RevenueFY20162016-01-01 to 2016-12-31$010-K2018-04-170001607062-18-000127
Net incomeFY20252025-01-01 to 2025-12-31$70,789,00010-K2026-03-050001628280-26-015168
Net incomeFY20242024-01-01 to 2024-12-31$52,097,00010-K2026-03-050001628280-26-015168
Net incomeFY20232023-01-01 to 2023-12-31-$45,787,00010-K2026-03-050001628280-26-015168
Net incomeFY20222022-01-01 to 2022-12-31-$424,780,44610-K/A2025-11-180001628280-25-052895
Net incomeFY20212021-01-01 to 2021-12-31$132,593,32810-K2024-03-290001558370-24-004287
Net incomeFY20202020-01-01 to 2020-12-31$105,969,88510-K2023-03-030001558370-23-002713
Net incomeFY20192019-01-01 to 2019-12-31-$7,116,52010-K2021-04-050001607062-21-000074
Net incomeFY20182018-01-01 to 2018-12-31-$950,12910-K2020-05-140001607062-20-000125
Net incomeFY20172017-01-01 to 2017-12-31$582,06210-K/A2019-04-170001607062-19-000163
Net incomeFY20162016-01-01 to 2016-12-31-$7,432,24110-K2018-04-170001607062-18-000127
  • Revenue for FY2024 was restated: first reported as $479,948,633 (accession 0001479681-25-000006, filed 2025-03-31).
  • Revenue for FY2023 was restated: first reported as $247,646,316 (accession 0001558370-24-004287, filed 2024-03-29).
  • Revenue for FY2021 was restated: first reported as $18,793,783 (accession 0001607062-22-000229, filed 2022-03-31).
  • Revenue for FY2020 was restated: first reported as $1,585,952 (accession 0001607062-21-000074, filed 2021-04-05).
  • Revenue for FY2018 was restated: first reported as $60,224 (accession 0001607062-19-000163, filed 2019-04-17).
  • Net income for FY2024 was restated: first reported as $52,179,168 (accession 0001479681-25-000006, filed 2025-03-31).
  • Net income for FY2023 was restated: first reported as -$45,786,614 (accession 0001558370-24-004287, filed 2024-03-29).
  • Net income for FY2021 was restated: first reported as -$13,668,624 (accession 0001607062-22-000229, filed 2022-03-31).
  • Net income for FY2020 was restated: first reported as -$5,650,167 (accession 0001607062-21-000074, filed 2021-04-05).
  • Net income for FY2018 was restated: first reported as -$2,814,245 (accession 0001607062-19-000163, filed 2019-04-17).

Recent 10-K and 10-Q filings

The 12 most recent 10-K, 10-Q and amendment filings in EDGAR, newest first.

FormFiledPeriod of reportAccession numberDocument
10-Q2026-08-062026-06-300001628280-26-054268nutx-20260630.htm
10-Q2026-04-302026-03-310001628280-26-028849nutx-20260331.htm
10-K2026-03-052025-12-310001628280-26-015168nutx-20251231.htm
10-Q2025-11-192025-09-300001628280-25-053166nutx-20250930.htm
10-Q2025-11-182025-06-300001628280-25-052957nutx-20250630.htm
10-Q/A2025-11-182025-03-310001628280-25-052951nutx-20250331.htm
10-K/A2025-11-182024-12-310001628280-25-052895nutx-20241231.htm
10-Q2025-05-132025-03-310001479681-25-000022nutx-20250331x10q.htm
10-K/A2025-04-302024-12-310001479681-25-000014nutx-20241231x10ka.htm
10-K2025-03-312024-12-310001479681-25-000006nutx-20241231x10k.htm
10-Q2024-11-072024-09-300001479681-24-000014nutx-20240930x10q.htm
10-Q2024-08-082024-06-300001479681-24-000007nutx-20240630x10q.htm

Identifier registry

The company's identifiers in the Olympus identifier registry, each with how it was linked and its source.

SchemeValueHow linkedSourcePublished
SEC Central Index Key (CIK) · OLY-US-SEC-CIK0001479681published by the sourcedata.sec.gov/submissions/CIK0001479681.json2026-10-21
Employer Identification Number (EIN) · US-EIN11-3363609published by the sourcedata.sec.gov/submissions/CIK0001479681.json2026-10-21

Former names

NameFromTo
Nutex Health, Inc.2022-04-042026-02-11
Clinigence Holdings, Inc.2019-11-142022-03-31
iGambit, Inc.2009-12-312019-11-13

Sources

  • EDGAR submissions (nightly bulk archive) (company profile and filings) — U.S. Securities and Exchange Commission. EDGAR snapshot sha256:f7d2a4f18cb91aae, source date 2026-10-20. https://data.sec.gov/submissions/CIK0001479681.json
  • EDGAR XBRL company facts (nightly bulk archive) (financial metrics) — U.S. Securities and Exchange Commission. EDGAR snapshot sha256:01e4045aa34d7224, source date 2026-10-20. https://data.sec.gov/api/xbrl/companyfacts/CIK0001479681.json
  • Published by Olympus on Oct 21, 2026.
  • Source data: U.S. Securities and Exchange Commission (EDGAR). Values are as filed by the registrant; Olympus does not audit or adjust them.
  • Olympus is not affiliated with or endorsed by the U.S. Securities and Exchange Commission.

Get this data from the API

The same figures, with provenance on every value, from the API (free API key, reference) or from an AI agent through the Olympus MCP server.

curl
curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001479681" -H "X-API-Key: $OLYMPUS_API_KEY"

curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001479681/financials" -H "X-API-Key: $OLYMPUS_API_KEY"

curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001479681/filings?limit=12" -H "X-API-Key: $OLYMPUS_API_KEY"
MCP tool call
get_sec_company_financials {"cik":"1479681"}

On SEC EDGAR

About this data